(Q40079119)

17 September 2017

title

The single nucleotide polymorphism A118G alters functional properties of the human mu opioid receptor (English)

1 reference

single-nucleotide polymorphism

17 September 2017

0 references

1 reference

Mary Jeanne Kreek

1 reference

17 September 2017

Thomas Kroslak

1 reference

17 September 2017

K Steven Laforge

1 reference

17 September 2017

Robert J Gianotti

1 reference

17 September 2017

Ann Ho

1 reference

17 September 2017

David A Nielsen

1 reference

17 September 2017

language of work or name

English

0 references

publication date

1 October 2007

1 reference

Journal of Neurochemistry

17 September 2017

published in

1 reference

17 September 2017

volume

103

1 reference

17 September 2017

1 reference

17 September 2017

page(s)

77-87

1 reference

Nalmefene induced elevation in serum prolactin in normal human volunteers: partial kappa opioid agonist activity?

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04738.X

Increased attributable risk related to a functional mu-opioid receptor gene polymorphism in association with alcohol dependence in central Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04738.X

A single nucleotide polymorphic mutation in the human mu-opioid receptor severely impairs receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04738.X

Mu opioid receptor gene variants: lack of association with alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04738.X

Human mu opioid receptor gene polymorphisms and vulnerability to substance abuse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04738.X

Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04738.X

Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04738.X

mu Opioid receptor: role for the amino terminus as a determinant of ligand binding affinity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04738.X

Genetics of two mu opioid receptor gene (OPRM1) exon I polymorphisms: population studies, and allele frequencies in alcohol- and drug-dependent subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04738.X

Sequence variability and candidate gene analysis in complex disease: association of mu opioid receptor gene variation with substance dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04738.X

Association of functional opioid receptor genotypes with alcohol dependence in Koreans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04738.X

Pharmacotherapy of addictions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04738.X

Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04738.X

Opioid receptor and peptide gene polymorphisms: potential implications for addictions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04738.X

A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04738.X

Amino acid 49 polymorphisms of the human beta1-adrenergic receptor affect agonist-promoted trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04738.X

The carboxyl terminus of the human calcium receptor. Requirements for cell-surface expression and signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04738.X

Identification of the sites of N-linked glycosylation on the human calcium receptor and assessment of their role in cell surface expression and signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04738.X

Nalmefene causes greater hypothalamic-pituitary-adrenal axis activation than naloxone in normal volunteers: implications for the treatment of alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04738.X

Stress-induced cocaine craving and hypothalamic-pituitary-adrenal responses are predictive of cocaine relapse outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04738.X

Association between mu opioid receptor gene polymorphisms and Chinese heroin addicts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04738.X

The mu-opioid receptor gene polymorphism (A118G) alters HPA axis activation induced by opioid receptor blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04738.X

Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04738.X

10.1111/J.1471-4159.2007.04738.X

21 January 2018

Identifiers

DOI

1 reference

17 September 2017

1 reference